[1] | Nazmi AS, Ahmad SJ, Rashikh A, Akhtar M, Pillai KK, Najmi AK. Khamira Abresham Hakim Arshad Wala 'a Unani formulation' protects against doxorubicin-induced cardiotoxicity and nephrotoxicity. Toxicol Mech Methods. 2011 Jan; 21(1):41-7. |
[2] | M. Aqil, A.K.Najmi, Alka Ahuja, A.S. Nazmi. Effective patient counseling: A mantra for the successful therapy. Souvenir, Muscat Pharmaceutical conference, 22-23 April, 2009, Pages 159-162. |
[3] | Nazmi AS. Drug development process: an overview. Souvenir, Muscat Pharmaceutical conference, 22-23 April, 2009, Pages 126-129. |
[4] | Najmi AK, Pillai KK, Jameel SJ, Nazmi AS. Diabetes mellitus: An insight into the pathogenesis. Journal of Science and Pharmacy 2002; 3(1): 12-15. |
[5] | Siddiqui MAA, Nazmi AS, Karim S, Razia K, Shanthi NP, Pillai KK. Effect of Melatonin and Valproate in Epilepsy and Depression. Indian Journal of Pharmacology 2001; 33: 378-381 |
[6] | Najmi AK, Pillai KK, Jameel SJ, Nazmi AS. Jigrine: a reappraisal of its medicinal ingredients. Hamdard Medicus 2001; XLIV (4): 34-39. |
[7] | Karim S, Bhandari U, Kumar H, Nazmi AS, Siddiqui MAA, Pillai KK. Doxorubicin induced cardiotoxicity and its modulation by drugs. Indian Journal of Pharmacology 2001; 33: 203-207. |
[8] | Siddiqui MAA, Nazmi AS, Razia K, Shanthi NP, Pillai KK. Oxidative damage in mice liver induced by sodium valproate: Protection by melatonin Indian Journal of Pharmacology 1999; 31: 427-430. |